Dallah Healthcare Co (SAU:4004) 5-Year EBITDA Growth Rate : 22.00% (As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Dallah Healthcare Co 5-Year EBITDA Growth Rate?

Dallah Healthcare Co's EBITDA per Share for the three months ended in Mar. 2024 was ﷼2.00.

During the past 12 months, Dallah Healthcare Co's average EBITDA Per Share Growth Rate was 13.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 27.50% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 22.00% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 10.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Dallah Healthcare Co was 27.50% per year. The lowest was -8.50% per year. And the median was 9.30% per year.

Competitive Comparison of Dallah Healthcare Co's 5-Year EBITDA Growth Rate

For the Medical Care Facilities subindustry, Dallah Healthcare Co's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dallah Healthcare Co's 5-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Dallah Healthcare Co's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Dallah Healthcare Co's 5-Year EBITDA Growth Rate falls into.

Dallah Healthcare Co 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Dallah Healthcare Co (SAU:4004) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Dallah Healthcare Co 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Dallah Healthcare Co's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Dallah Healthcare Co (SAU:4004) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Dallah Healthcare Co (SAU:4004) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

1157 King Fahad Road, Nakheel building, 2nd Floor, Riyadh, SAU, 12381

Website

https://www.dallahhealth.com

Dallah Healthcare Co provides and operates healthcare programs and utilities in the Kingdom of Saudi Arabia. The objectives of the company include operating, managing and maintaining the healthcare entities, wholesale medicines and retail of medical and surgical equipment, prosthetics and devices for the disabled, hospital equipment and manufacturing medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants and the packaging in the Kingdom of Saudi Arabia. The reportable segments of the company are Medical Service/Medicine and Pharmaceutical products. The majority of the company's revenue is earned from the Medical service segment.

Dallah Healthcare Co (SAU:4004) Headlines

No Headlines